Yu Du

2PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 25, 2023
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma.

Yu Du, Jie Dai, Lili Mao

Pageof 1